• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Am Pharm Rev 2011 May-Jun;14(4):37370

Historical Overview of Mycoplasma Testing for Production of Biologics

Chandler DKF, Volokhov DV, Chizhikov VE

Abstract

This review summarizes the evolution of mycoplasma testing methods as well as the historical development of requirements and recommendations for testing of vaccines and biologics produced in cell substrates. Although newly emerged molecular technologies provide a real possibility to expedite mycoplasma testing, the historical experience accumulated during evaluation and implementation of mycoplasma testing methods may be useful for the identification of challenges associated with the comparability between different methods, particularly when comparable tests rely on detection of different biological features of mycoplasmas. Even though mycoplasma contamination during production of biological products has been recognized for many years, a global consensus regarding the most appropriate testing methods for biological products has not yet been reached, as evidenced by the variations in the regulatory and compendial requirements and guidance recommendations.


Category: Journal Article, Review
Includes FDA Authors from Scientific Area(s): Biologics
Entry Created: 2011-10-04 Entry Last Modified: 2012-08-29
Feedback
-
-